SIGA: SIGA Technologies, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 372.90
Enterprise Value ($M) 217.50
Book Value ($M) 215.80
Book Value / Share 3.02
Price / Book 1.73
NCAV ($M) 202.51
NCAV / Share 2.83
Price / NCAV 1.84

Profitability (mra)
Return on Invested Capital (ROIC) 0.27
Return on Assets (ROA) 0.24
Return on Equity (ROE) 0.36

Liquidity (mrq)
Quick Ratio 7.16
Current Ratio 9.12

Balance Sheet (mrq) ($M)
Current Assets 231.04
Assets 244.34
Liabilities 28.53
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 138.72
Operating Income 69.98
Net Income 59.21
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 48.76
Cash from Investing -0.04
Cash from Financing -43.46

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-08 13G BlackRock, Inc. 5.60 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-11 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-04 97,222 410,921 23.66
2025-04-03 60,478 318,298 19.00
2025-04-02 44,874 289,055 15.52
2025-04-01 48,181 264,037 18.25
2025-03-31 44,821 164,913 27.18

(click for more detail)

Similar Companies
SAGE – Sage Therapeutics, Inc. SCYX – SCYNEXIS, Inc.
SGMT – Sagimet Biosciences Inc. SKYE – Skye Bioscience, Inc.
SMMT – Summit Therapeutics Inc.


Financial data and stock pages provided by
Fintel.io